Radiation Therapy Trials - Quality Assurance:  patient safety  adherence to protocol constraints  uniformity of patient treatments  efficient review.

Slides:



Advertisements
Similar presentations
Please note, these are the actual video-recorded proceedings from the live CME event and may include the use of trade names and other raw, unedited content.
Advertisements

PLENARY SESSION Fall Group Meeting Miami, FL November 13, 2010.
RapidArc plan verification using ArcCHECK™
Commissioning an Anthropomorphic Spine and Lung Phantom for Remote Dose Verification of Institutions Participating in RTOG 0631 Douglas Caruthers, M.S.;
Guideline for Monitoring of Clinical Trials for Cooperative Groups, CCOP Research Bases, and the Clinical Trials Support Unit (CTSU) Lore Lagrone Program.
Slice Thickness Interpolation: The effect of interpolated slice thickness on the 2D vs 3D gamma results are shown in Table 3 for the QA data set only.
FDA-QA-DAS/2010 FDA’s Public Meeting: Device Improvements to Reduce the Number of Under-doses, Over-doses, and Misaligned Exposures from Therapeutic Radiation.
Challenges in Credentialing Institutions and Participants in Advanced Technology Clinical Trials Geoffrey Ibbott, David Followill, Andrea Molineu, Jessica.
Algorithms used in heterogeneous dose calculations show systematic error as measured with the Radiological Physics Center’s anthropomorphic thorax phantom.
Advances in Early Diagnosis and Treatment of Cancer July 17, 2007.
Background:  IMRT has become the choice of treatment for disease sites that require critical structure sparing such as head and neck cancer.  It has.
Innovation/Impact: By designing a simulated human shaped (anthropomorphic) plastic phantom with targets, organs at risk (OAR) and heterogeneities, the.
Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board Part 1.
COMPUTERS AND RADIATION THERAPY/ONCOLOGY Lydia Eichler CIS 109.
Volumetric Multimodality Imaging and Planning Data: A Challenge for Cooperative Group Clinical Trials James A. Purdy, Ph.D. Professor and Director Division.
Radiotherapy Treatment Planning
Results The measured-to-predicted dose ratio criteria used by the RPC to credential institutions is , however for this work, a criteria of
11. – , Athens 8th European Conference on Medical Physics DOSIMETRY AUDITS IN RADIOTHERAPY IN THE CZECH REPUBLIC Irena Koniarová Daniela Ekendahl.
به نام خداوند بخشایندۀ بخشایشگر
 Quality & Safety Considerationsin Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy.
CALGB Informational Session June 22, 2007 David Hurd, MD Interim Chair Data Audit Committee.
Quality Control in Radiation Therapy, A New Concept: Dosimetry Check
Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation.
Patient Plan Results: Table 3 shows the ratio of the Pinnacle TPS calculation to the DPM recalculation for the mean dose from selected regions of interest.
Annual Meeting 2011 Clinical Trial Development Clinical Trial Development: OEWG, RA’s Role, and Activating Trials on Deadline Martha Heckel Protocol Associate.
CTEP, NCI Adverse Event Reporting Programmatic & Workflow Processes Prepared by: Ann Setser May 24, 2010.
Applications of Geant4 in Proton Radiotherapy at the University of Texas M.D. Anderson Cancer Center Jerimy C. Polf Assistant Professor Department of Radiation.
Comparison of Clinical Parameters for Proton Therapy in the United States Paige Summers, MS.
DICOM Anniversary Conference Experience Using DICOM-RT Objects for Clinical Trials QA Walter R. Bosch, D.Sc., John W. Matthews, D.Sc., Vincent A. Frouhar,
Surface dose prediction and verification for IMRT plans using line dose profiles † Ronald E. Berg, † Michael S. Gossman and ‡ Stephen J. Klash † Erlanger.
Phase III Clinical Trials with Protons: Their importance for Patient Centered Care for: NCI Workshop on Advanced Technologies in Radiation Oncology: Examining.
IMRT QA Plan Site 5%/3mm3%/3mm2%/2mm 0% noise1% noise2% noise0% noise1% noise2% noise0% noise1% noise2% noise HN
The RPC Proton Therapy Approval Process
FDA Public Meeting: Device Improvements to Reduce the Number of Under-doses and Misaligned Exposures from Therapeutic Radiation.
Chair:Dr. Vivien Bramwell NATIONAL CANCER INSTITUTE OF CANADA CLINICAL TRIALS GROUP Sarcoma Committee CANADIAN SARCOMA GROUP.
OEWG Kick-Off Meeting Meg Mooney, MD Chief, Clinical Investigations Branch CTEP, DCTD, NCI – March 24, 2010 CTEP & Cooperative Group Plans for OEWG Implementation:
Institute for Advanced Radiation Oncology
Gynecologic Oncology Group Gynecologic Oncology Group (GOG) Sharon Stockman, C-CRC The University of Iowa Hospitals Iowa City, IA Chair, GOG Data Management.
Radiological Physics Center David Followill, Ph.D. and RPC Staff.
Scanner Validation via the SNM Clinical Trials Network Phantom Program Paul E. Christian Molecular Imaging Program Huntsman Cancer Institute University.
The Radiological Physics Center’s Anthropomorphic Quality Assurance Phantom Program Carrie F. Amador, Nadia Hernandez, Andrea Molineu, Paola Alvarez, and.
1 A Comprehensive Study on the Heterogeneity Dose Calculation Accuracy in IMRT using an Anthropomorphic Thorax Phantom S Davidson 1, R Popple 2, G Ibbott.
Investigation of 3D Dosimetry for an Anthropomorphic Spine Phantom R. Grant 1,2, G. Ibbott 1, J. Yang 1, J. Adamovics 3, D Followill 1 (1)M.D. Anderson.
Workshop on Advanced Technologies in Radiation Oncology Kian Ang.
K. Pulliam, MS 1,2., D Followill, PhD 2., L Court, PhD 2., L Dong, PhD 3., M Gillin, PhD 2., K Prado, PhD 3., S Kry, PhD 2 1 The University of Texas Graduate.
Introduction The Radiological Physics Center (RPC) anthropomorphic quality assurance (QA) phantom program is one tool the RPC uses to remotely audit institutions.
Enrollment and Monitoring Procedures for NCI Supported Clinical Trials Barry Anderson, MD, PhD Cancer Therapy Evaluation Program National Cancer Institute.
Preliminary External and Internal Dosimetry Data from a new set of mother/fetus models JY Zhang, V Taranenko, D Zhang, X. George Xu, Rensselaer Polytechnic.
ECOG-ACRIN Imaging Research Associate Education Symposium November 12, 2015.
TLD POSTAL DOSE QUALITY AUDIT FOR 6MV AND 15MV PHOTON BEAMS IN RADIOTHERAPY CLINICAL PRACTICE Sonja Petkovska 1, Margarita Ginovska 2, Hristina Spasevska.
R.T. Quality Assurance Robert Lustig, MD Robert Lustig, MD James Galvin, D.Sc., RTOG Group Physicist James Galvin, D.Sc., RTOG Group Physicist Ying Xiao,
Flair development for the MC TPS Wioletta Kozłowska CERN / Medical University of Vienna.
Purpose N-isopropylacrylamide (NIPAM) polymer gel dosimeters were employed to verify the dose distribution of clinical intensity modulated radiation therapy.
CERTIFICATION OF MEDICAL PHYSICIST – INDIAN PERSPECTIVE DR. ARUN CHOUGULE ; Ph.D. ASSOCAITE PROF. RADIATION PHYSICS & RSO INCHARGE TELEMEDICINE S.M.S.
SARC018: A SARC PILOT MULTICENTER STUDY OF PREOPERATIVE RADIATION AND SURGERY IN PATIENTS WITH HIGH- RISK DESMOID TUMORS Robert S. Benjamin, M.D.
11 Radiation Therapy Oncology Group Clinical Trials Administration Sharon Hartson Stine, Director Group Administrator.
Development of elements of 3D planning program for radiotherapy Graphical editor options  automated enclose of contour  correction of intersections 
CTTI PROJECT Emory University, Quality Assurance and Review Center (QARC) and Washington University in St. Louis.
Retroactive Calculation of TLD and Film Dose in Anthropomorphic Phantom as Assessment of Updated TPS Performance H. Alkhatib 1, S. Oves 1, B. Tsang 1,
How to Navigate the NCTN and Participate in Imaging Research
INTRODUCTION RESULTS DATA ANALYSIS DISCUSSION METHODS REFERENCES
Evaluation Of RTOG Guidelines For Monte Carlo Based Lung SBRT Planning
RTOG ELECTRONIC DATA SUBMISSION
Left Posterior Superior Right Anterior Inferior
Fig. 4. Percentage of passing rate between clinical and 544 plans.
A Multi-Institutional Dosimetric Evaluation of Proton Versus Photon Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma F. Khan, B. Nguyen,
Cooperative Group Clinical Trials in General Thoracic Surgery: Report From the 2012 Robert Ginsberg Clinical Trials Meeting of the General Thoracic Surgical.
Chapter 17 Intensity-Modulated Radiation Therapy
GHG meeting at ESTRO36 May, 2017
SBRT trial QA IROC GHG meeting at ESTRO May, 2017
Presentation transcript:

Radiation Therapy Trials - Quality Assurance:  patient safety  adherence to protocol constraints  uniformity of patient treatments  efficient review of patient data

CTEP supported CLINICAL TRIAL QA CENTERS RTOG, Philadelphia (RTOG) QARC, Providence (COG, CALGB, SWOG, ECOG, ACOSOG, ) RPC, MD Anderson (NSABP, GOG and physical dose QA for ALL groups) Review item: chart: images: study chairs: archives: ATC cooperative agreement developmental: ITC, RCET implementation: RTOG, QARC, RPC Conventional Post Tx Few – hard copy- largely 2D Travel to QA center Hard copy- difficult searches Advanced tech trials Real-time and pre-Tx Gbytes of digital – multi modality Remote review by internet Digital full datasets

RPC IMRT Phantom Test RPC tests ability of each institution to deliver IMRT by asking facility to: –Scan RPC phantom (CT, MRI, etc.) –Generate an IMRT plan according to defined protocol –Deliver treatment to phantom –Return phantom and dosimeters to RPC for evaluation. –Submit digital planning data to the ITC –RPC uses ATC Remote Review Tool to analyze data TLDs

Phantom Results Comparison between institution’s plan and delivered dose. Criteria for agreement: 7% or 4 mm DTA * 30% of institutions failed H&N phantom on the first attempt PhantomH&NProstateThoraxLiver Irradiations Pass 179*55173 Fail Under analysis or at institution Year introduced2001Spring 2004 Spring 2005

RTOG 0022 Dry-Run Test PHASE I/II STUDY OF CONFORMAL AND INTENSITY MODULATED IRRADIATION FOR OROPHARYNGEAL CANCER Of 18 Institutions* that were ultimately credentialed: Number of submissions it took to meet credentialing guidelines 6 institutions required 1 submission 9 institutions required 2 submissions 3 institutions required 3 submissions ( * these were large academic centers)

NCI IMRT PROTOCOL REQUIREMENTS 2002: guidelines for IMRT use in clinical trials were established to ensure the safety and comparability of these radiation treatments. 2005: NCI announced revisions in these guidelines allowing use of IMRT for intra-thoracic treatments. 2006: specific guidelines for use of IMRT for intra-thoracic treatment protocols with respiratory gating

ISSUES (some) CONCERNING PROTON THERAPY ( multi-institutional trails ) 1) No national standard for proton calibration 2) Two different calibration protocols in use among US facilities 3) RPC still developing methods for remote review of dosimetry ( TLD?) 4) RPC still developing a proton compatible phantom 5) ATC still verifying compatibility of proton Tx planning computers 6) Proton dose computation algorithms standards at the QA centers in addition to secondary neutron production modeling 7) Protocol specific: field placement verification, critical nature of heterogeneity corrections, GTV margins re: SOBP distal edge dosimetry and lateral penumbra,